Sonia Dupont
Romainville, 93230, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases.
Journal: Journal of medicinal chemistry
Published: March 29, 2024
IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases.
Journal: Science translational medicine
Published: February 15, 2023
Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS-5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip.
Journal: Clinical pharmacology in drug development
Published: April 19, 2021
GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects.
Journal: Clinical pharmacology in drug development
Published: October 16, 2020
Discovery of 9-Cyclopropylethynyl-2-((S)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one (GLPG1205), a Unique GPR84 Negative Allosteric Modulator Undergoing Evaluation in a Phase II Clinical Trial.
Journal: Journal of medicinal chemistry
Published: September 09, 2020
Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials.
Journal: Journal of clinical pharmacology
Published: November 29, 2018
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial.
Journal: The Lancet. Respiratory medicine
Published: March 08, 2018
Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis.
Journal: The Journal of investigative dermatology
Published: September 14, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026